Which has better earnings & valuation, PLMR or RYAN?

Palomar has higher earnings, but lower revenue than Ryan Specialty. Palomar is trading at a lower price-to-earnings ratio than Ryan Specialty, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Palomar $875.97M 3.82 $197.07M $7.18 17.59 Ryan Specialty $3.16B 3.26 $63.40M $0.77 50.70

Is PLMR or RYAN more profitable?

Palomar has a net margin of 20.11% compared to Ryan Specialty's net margin of 8.21%. Ryan Specialty's return on equity of 41.33% beat Palomar's return on equity. Company Net Margins Return on Equity Return on Assets Palomar 20.11% 22.62% 6.60% Ryan Specialty 8.21% 41.33% 4.80%

Does the media prefer PLMR or RYAN?

In the previous week, Palomar had 25 more articles in the media than Ryan Specialty. MarketBeat recorded 29 mentions for Palomar and 4 mentions for Ryan Specialty. Ryan Specialty's average media sentiment score of 0.59 beat Palomar's score of 0.29 indicating that Ryan Specialty is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Palomar 6 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral Ryan Specialty 2 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has better earnings & valuation, PLMR or OSCR?

Palomar has higher earnings, but lower revenue than Oscar Health. Oscar Health is trading at a lower price-to-earnings ratio than Palomar, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Palomar $875.97M 3.82 $197.07M $7.18 17.59 Oscar Health $13.30B 0.67 -$443.15M -$0.59 N/A

Is PLMR or OSCR more profitable?

Palomar has a net margin of 20.11% compared to Oscar Health's net margin of -0.30%. Palomar's return on equity of 22.62% beat Oscar Health's return on equity. Company Net Margins Return on Equity Return on Assets Palomar 20.11% 22.62% 6.60% Oscar Health -0.30% -3.26% -0.57%

Does the media prefer PLMR or OSCR?

In the previous week, Palomar had 18 more articles in the media than Oscar Health. MarketBeat recorded 29 mentions for Palomar and 11 mentions for Oscar Health. Oscar Health's average media sentiment score of 0.39 beat Palomar's score of 0.29 indicating that Oscar Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Palomar 6 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral Oscar Health 4 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has better valuation & earnings, VOYA or PLMR?

Voya Financial has higher revenue and earnings than Palomar. Voya Financial is trading at a lower price-to-earnings ratio than Palomar, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Voya Financial $8.19B 1.00 $654M $6.62 13.70 Palomar $875.97M 3.82 $197.07M $7.18 17.59

Is VOYA or PLMR more profitable?

Palomar has a net margin of 20.11% compared to Voya Financial's net margin of 8.24%. Palomar's return on equity of 22.62% beat Voya Financial's return on equity. Company Net Margins Return on Equity Return on Assets Voya Financial 8.24% 13.84% 0.52% Palomar 20.11% 22.62% 6.60%

Does the media refer more to VOYA or PLMR?

In the previous week, Palomar had 25 more articles in the media than Voya Financial. MarketBeat recorded 29 mentions for Palomar and 4 mentions for Voya Financial. Voya Financial's average media sentiment score of 1.16 beat Palomar's score of 0.29 indicating that Voya Financial is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Voya Financial 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Palomar 6 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral

Does the media refer more to JXN or PLMR?

In the previous week, Palomar had 25 more articles in the media than Jackson Financial. MarketBeat recorded 29 mentions for Palomar and 4 mentions for Jackson Financial. Palomar's average media sentiment score of 0.29 beat Jackson Financial's score of 0.29 indicating that Palomar is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Jackson Financial 0 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Palomar 6 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral

Which has higher valuation & earnings, KNSL or PLMR?

Kinsale Capital Group has higher revenue and earnings than Palomar. Kinsale Capital Group is trading at a lower price-to-earnings ratio than Palomar, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Kinsale Capital Group $1.87B 4.07 $503.61M $22.72 14.57 Palomar $875.97M 3.82 $197.07M $7.18 17.59

Does the media refer more to KNSL or PLMR?

In the previous week, Palomar had 26 more articles in the media than Kinsale Capital Group. MarketBeat recorded 29 mentions for Palomar and 3 mentions for Kinsale Capital Group. Kinsale Capital Group's average media sentiment score of 1.10 beat Palomar's score of 0.29 indicating that Kinsale Capital Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Kinsale Capital Group 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Palomar 6 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral

Palomar (PLMR) Competitors

$126.33 +0.01 (+0.01%)

Closing price 06/29/2026 04:00 PM Eastern

Extended Trading

$127.00 +0.67 (+0.53%)

As of 06/29/2026 06:56 PM Eastern

Compare

PLMR vs. RYAN, OSCR, VOYA, JXN, and KNSL

Should you buy Palomar stock or one of its competitors? MarketBeat compares Palomar with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Palomar include Ryan Specialty (RYAN), Oscar Health (OSCR), Voya Financial (VOYA), Jackson Financial (JXN), and Kinsale Capital Group (KNSL). These companies are all part of the "insurance" industry.

How does Palomar compare to Ryan Specialty?

Palomar (NASDAQ:PLMR) and Ryan Specialty (NYSE:RYAN) are both finance companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, valuation, institutional ownership, risk, profitability, earnings, media sentiment and analyst recommendations.

In the previous week, Palomar had 25 more articles in the media than Ryan Specialty. MarketBeat recorded 29 mentions for Palomar and 4 mentions for Ryan Specialty. Ryan Specialty's average media sentiment score of 0.59 beat Palomar's score of 0.29 indicating that Ryan Specialty is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Palomar	6 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral
Ryan Specialty	2 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Palomar has a net margin of 20.11% compared to Ryan Specialty's net margin of 8.21%. Ryan Specialty's return on equity of 41.33% beat Palomar's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Palomar	20.11%	22.62%	6.60%
Ryan Specialty	8.21%	41.33%	4.80%

Palomar has higher earnings, but lower revenue than Ryan Specialty. Palomar is trading at a lower price-to-earnings ratio than Ryan Specialty, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Palomar	$875.97M	3.82	$197.07M	$7.18	17.59
Ryan Specialty	$3.16B	3.26	$63.40M	$0.77	50.70

Palomar presently has a consensus price target of $147.75, indicating a potential upside of 16.96%. Ryan Specialty has a consensus price target of $47.12, indicating a potential upside of 20.68%. Given Ryan Specialty's higher possible upside, analysts plainly believe Ryan Specialty is more favorable than Palomar.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Palomar	0 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.67
Ryan Specialty	3 Sell rating(s)	7 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.37

Palomar has a beta of 0.44, suggesting that its share price is 56% less volatile than the broader market. Comparatively, Ryan Specialty has a beta of 0.64, suggesting that its share price is 36% less volatile than the broader market.

90.3% of Palomar shares are owned by institutional investors. Comparatively, 84.8% of Ryan Specialty shares are owned by institutional investors. 3.7% of Palomar shares are owned by insiders. Comparatively, 52.0% of Ryan Specialty shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Summary

Ryan Specialty beats Palomar on 9 of the 17 factors compared between the two stocks.

How does Palomar compare to Oscar Health?

Palomar (NASDAQ:PLMR) and Oscar Health (NYSE:OSCR) are both mid-cap finance companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, valuation, analyst recommendations, media sentiment, profitability, earnings, dividends and risk.

Palomar has higher earnings, but lower revenue than Oscar Health. Oscar Health is trading at a lower price-to-earnings ratio than Palomar, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Palomar	$875.97M	3.82	$197.07M	$7.18	17.59
Oscar Health	$13.30B	0.67	-$443.15M	-$0.59	N/A

In the previous week, Palomar had 18 more articles in the media than Oscar Health. MarketBeat recorded 29 mentions for Palomar and 11 mentions for Oscar Health. Oscar Health's average media sentiment score of 0.39 beat Palomar's score of 0.29 indicating that Oscar Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Palomar	6 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral
Oscar Health	4 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Palomar has a net margin of 20.11% compared to Oscar Health's net margin of -0.30%. Palomar's return on equity of 22.62% beat Oscar Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Palomar	20.11%	22.62%	6.60%
Oscar Health	-0.30%	-3.26%	-0.57%

Palomar currently has a consensus target price of $147.75, suggesting a potential upside of 16.96%. Oscar Health has a consensus target price of $20.78, suggesting a potential downside of 29.26%. Given Palomar's stronger consensus rating and higher possible upside, research analysts plainly believe Palomar is more favorable than Oscar Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Palomar	0 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.67
Oscar Health	1 Sell rating(s)	8 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.17

90.3% of Palomar shares are held by institutional investors. Comparatively, 75.7% of Oscar Health shares are held by institutional investors. 3.7% of Palomar shares are held by company insiders. Comparatively, 25.1% of Oscar Health shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Palomar has a beta of 0.44, indicating that its stock price is 56% less volatile than the broader market. Comparatively, Oscar Health has a beta of 2.37, indicating that its stock price is 137% more volatile than the broader market.

Summary

Palomar beats Oscar Health on 12 of the 16 factors compared between the two stocks.

How does Palomar compare to Voya Financial?

Voya Financial (NYSE:VOYA) and Palomar (NASDAQ:PLMR) are both mid-cap finance companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, media sentiment, risk, institutional ownership, earnings, profitability, valuation and analyst recommendations.

Palomar has a net margin of 20.11% compared to Voya Financial's net margin of 8.24%. Palomar's return on equity of 22.62% beat Voya Financial's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Voya Financial	8.24%	13.84%	0.52%
Palomar	20.11%	22.62%	6.60%

96.1% of Voya Financial shares are held by institutional investors. Comparatively, 90.3% of Palomar shares are held by institutional investors. 1.6% of Voya Financial shares are held by insiders. Comparatively, 3.7% of Palomar shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Voya Financial has a beta of 0.92, suggesting that its stock price is 8% less volatile than the broader market. Comparatively, Palomar has a beta of 0.44, suggesting that its stock price is 56% less volatile than the broader market.

Voya Financial currently has a consensus target price of $91.73, indicating a potential upside of 1.14%. Palomar has a consensus target price of $147.75, indicating a potential upside of 16.96%. Given Palomar's higher possible upside, analysts plainly believe Palomar is more favorable than Voya Financial.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Voya Financial	1 Sell rating(s)	2 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.75
Palomar	0 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.67

Voya Financial has higher revenue and earnings than Palomar. Voya Financial is trading at a lower price-to-earnings ratio than Palomar, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Voya Financial	$8.19B	1.00	$654M	$6.62	13.70
Palomar	$875.97M	3.82	$197.07M	$7.18	17.59

In the previous week, Palomar had 25 more articles in the media than Voya Financial. MarketBeat recorded 29 mentions for Palomar and 4 mentions for Voya Financial. Voya Financial's average media sentiment score of 1.16 beat Palomar's score of 0.29 indicating that Voya Financial is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Voya Financial	3 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Palomar	6 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral

Summary

Palomar beats Voya Financial on 9 of the 17 factors compared between the two stocks.

How does Palomar compare to Jackson Financial?

Jackson Financial (NYSE:JXN) and Palomar (NASDAQ:PLMR) are both mid-cap finance companies, but which is the better investment? We will compare the two companies based on the strength of their dividends, profitability, media sentiment, institutional ownership, risk, analyst recommendations, earnings and valuation.

Palomar has a net margin of 20.11% compared to Jackson Financial's net margin of 0.00%. Palomar's return on equity of 22.62% beat Jackson Financial's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Jackson Financial	N/A	17.21%	0.49%
Palomar	20.11%	22.62%	6.60%

Jackson Financial has a beta of 1.32, meaning that its share price is 32% more volatile than the broader market. Comparatively, Palomar has a beta of 0.44, meaning that its share price is 56% less volatile than the broader market.

Palomar has lower revenue, but higher earnings than Jackson Financial. Jackson Financial is trading at a lower price-to-earnings ratio than Palomar, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Jackson Financial	$5.70B	1.29	$27M	-$6.11	N/A
Palomar	$875.97M	3.82	$197.07M	$7.18	17.59

Jackson Financial presently has a consensus price target of $115.80, indicating a potential upside of 10.20%. Palomar has a consensus price target of $147.75, indicating a potential upside of 16.96%. Given Palomar's stronger consensus rating and higher possible upside, analysts plainly believe Palomar is more favorable than Jackson Financial.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Jackson Financial	0 Sell rating(s)	5 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.43
Palomar	0 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.67

90.0% of Jackson Financial shares are held by institutional investors. Comparatively, 90.3% of Palomar shares are held by institutional investors. 1.4% of Jackson Financial shares are held by company insiders. Comparatively, 3.7% of Palomar shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

In the previous week, Palomar had 25 more articles in the media than Jackson Financial. MarketBeat recorded 29 mentions for Palomar and 4 mentions for Jackson Financial. Palomar's average media sentiment score of 0.29 beat Jackson Financial's score of 0.29 indicating that Palomar is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Jackson Financial	0 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Palomar	6 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral

Summary

Palomar beats Jackson Financial on 14 of the 17 factors compared between the two stocks.

How does Palomar compare to Kinsale Capital Group?

Kinsale Capital Group (NYSE:KNSL) and Palomar (NASDAQ:PLMR) are both mid-cap finance companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, valuation, institutional ownership, dividends, risk, media sentiment, analyst recommendations and earnings.

Kinsale Capital Group has higher revenue and earnings than Palomar. Kinsale Capital Group is trading at a lower price-to-earnings ratio than Palomar, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Kinsale Capital Group	$1.87B	4.07	$503.61M	$22.72	14.57
Palomar	$875.97M	3.82	$197.07M	$7.18	17.59

Kinsale Capital Group has a beta of 0.91, indicating that its share price is 9% less volatile than the broader market. Comparatively, Palomar has a beta of 0.44, indicating that its share price is 56% less volatile than the broader market.

85.4% of Kinsale Capital Group shares are held by institutional investors. Comparatively, 90.3% of Palomar shares are held by institutional investors. 5.6% of Kinsale Capital Group shares are held by insiders. Comparatively, 3.7% of Palomar shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

In the previous week, Palomar had 26 more articles in the media than Kinsale Capital Group. MarketBeat recorded 29 mentions for Palomar and 3 mentions for Kinsale Capital Group. Kinsale Capital Group's average media sentiment score of 1.10 beat Palomar's score of 0.29 indicating that Kinsale Capital Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Kinsale Capital Group	3 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Palomar	6 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral

Kinsale Capital Group has a net margin of 27.48% compared to Palomar's net margin of 20.11%. Kinsale Capital Group's return on equity of 25.82% beat Palomar's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Kinsale Capital Group	27.48%	25.82%	8.20%
Palomar	20.11%	22.62%	6.60%

Kinsale Capital Group currently has a consensus target price of $374.90, indicating a potential upside of 13.24%. Palomar has a consensus target price of $147.75, indicating a potential upside of 16.96%. Given Palomar's stronger consensus rating and higher probable upside, analysts clearly believe Palomar is more favorable than Kinsale Capital Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Kinsale Capital Group	3 Sell rating(s)	7 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.82
Palomar	0 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.67

Summary

Kinsale Capital Group beats Palomar on 10 of the 16 factors compared between the two stocks.

Get Palomar News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PLMR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

PLMR vs. The Competition

Export

Metric	Palomar	INS Industry	Finance Sector	NASDAQ Exchange
Market Cap	$3.35B	$60.03B	$13.86B	$12.20B
Dividend Yield	N/A	1.81%	5.69%	6.22%
P/E Ratio	17.59	11.42	20.46	24.37
Price / Sales	3.82	1.76	128.26	102.32
Price / Cash	16.25	13.08	19.67	36.93
Price / Book	3.55	2.10	2.25	6.49
Net Income	$197.07M	$4.24B	$1.14B	$336.61M
7 Day Performance	8.83%	3.96%	0.73%	1.25%
1 Month Performance	18.02%	11.02%	1.41%	0.24%
1 Year Performance	-18.10%	12.37%	14.51%	30.16%

Palomar Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
PLMR Palomar	4.1645 of 5 stars	$126.33 +0.0%	$147.75 +17.0%	-17.6%	$3.35B	$875.97M	17.59	150	News Coverage Analyst Revision
RYAN Ryan Specialty	4.8891 of 5 stars	$33.46 -4.3%	$47.12 +40.8%	-42.4%	$9.22B	$3.05B	43.46	6,110
OSCR Oscar Health	2.904 of 5 stars	$28.53 +0.4%	$20.78 -27.2%	+44.2%	$8.56B	$11.70B	N/A	2,305	Positive News Insider Trade
VOYA Voya Financial	4.7762 of 5 stars	$92.31 +2.3%	$91.73 -0.6%	+28.1%	$8.18B	$8.04B	13.94	11,000
JXN Jackson Financial	2.3158 of 5 stars	$108.97 +2.0%	$115.80 +6.3%	+17.3%	$7.45B	$6.68B	N/A	3,890	News Coverage

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:PLMR) was last updated on 6/30/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Palomar (PLMR) Competitors

PLMR vs. RYAN, OSCR, VOYA, JXN, and KNSL

How does Palomar compare to Ryan Specialty?

Summary

How does Palomar compare to Oscar Health?

Summary

How does Palomar compare to Voya Financial?

Summary

How does Palomar compare to Jackson Financial?

Summary

How does Palomar compare to Kinsale Capital Group?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

PLMR vs. The Competition

Palomar Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Palomar (PLMR) Competitors

PLMR vs. RYAN, OSCR, VOYA, JXN, and KNSL

How does Palomar compare to Ryan Specialty?

Does the media prefer PLMR or RYAN?

Is PLMR or RYAN more profitable?

Which has better earnings & valuation, PLMR or RYAN?

Do analysts prefer PLMR or RYAN?

Which has more risk & volatility, PLMR or RYAN?

Do institutionals & insiders believe in PLMR or RYAN?

Summary

How does Palomar compare to Oscar Health?

Which has better earnings & valuation, PLMR or OSCR?

Does the media prefer PLMR or OSCR?

Is PLMR or OSCR more profitable?

Do analysts prefer PLMR or OSCR?

Do insiders and institutionals have more ownership in PLMR or OSCR?

Which has more risk & volatility, PLMR or OSCR?

Summary

How does Palomar compare to Voya Financial?

Is VOYA or PLMR more profitable?

Do insiders & institutionals believe in VOYA or PLMR?

Which has more risk and volatility, VOYA or PLMR?

Do analysts prefer VOYA or PLMR?

Which has better valuation & earnings, VOYA or PLMR?

Does the media refer more to VOYA or PLMR?

Summary

How does Palomar compare to Jackson Financial?

Is JXN or PLMR more profitable?

Which has more volatility & risk, JXN or PLMR?

Which has better earnings & valuation, JXN or PLMR?

Do analysts recommend JXN or PLMR?

Do institutionals and insiders believe in JXN or PLMR?

Does the media refer more to JXN or PLMR?

Summary

How does Palomar compare to Kinsale Capital Group?

Which has higher valuation & earnings, KNSL or PLMR?

Which has more volatility and risk, KNSL or PLMR?

Do institutionals & insiders believe in KNSL or PLMR?

Does the media refer more to KNSL or PLMR?

Is KNSL or PLMR more profitable?

Do analysts recommend KNSL or PLMR?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

PLMR vs. The Competition

Palomar Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools